, Singapore
396 views
Photo by Kampus Production via Pexels

Enigma Health partners with Roche, ST Engineering to boost AI healthcare solutions

ST Engineering will integrate Enigma’s AI model into its Genie Studio platform.

Enigma Health, a spinoff from SingHealth Duke-NUS Academic Medical Centre, has signed two strategic memorandums of understanding (MOUs) with global healthcare giant Roche and ST Engineering’s Enterprise Digital division.

The partnership with Roche will use Enigma Health’s AI workflow to speed up clinical trial recruitment, improve market access, and enhance business intelligence.

Meanwhile, the deal with ST Engineering’s Enterprise Digital focuses on joint exploration of new business and market opportunities. Enigma Health’s small language model will be incorporated into ST Engineering’s AGIL® Genie Studio platform, enabling non-technical users to develop AI-powered healthcare applications more easily.

The partnership combines SingHealth’s clinical expertise with ST Engineering’s hospital command centre data management to improve healthcare operations, decision-making, and AI-driven clinical trials.

Enigma Health said it will also work with national HealthTech agency Synapxe to expand its platform across SingHealth and plans to grow its reach in Southeast Asia with pharma companies and healthcare providers.

The announcement was made by Minister of State Mdm Rahayu Mahzam at the “Scaling and Sustaining Healthcare with Gen AI” symposium at ATxSG 2025.
 

Join Singapore Business Review community

Follow the link for more news on

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Top News

September surge masks looming export slowdown to 6% in 2027
Maybank raised its 2026 forecast to 27% from 18% in the same report.Non-oil domestic exports (NODX) growth could slow to 6% in 2027 as supply chain pressures and higher financing costs weigh on shipment momentum, Maybank Research Pte Ltd said.
Economy